Dose Insider / GLP-1 sellers / MEDVi

MEDViPrices, drugs and FDA record

Read on medvi.org on November 20, 2026

MEDVi sells GLP-1 weight-loss care online through medvi.org. Its site names Ozempic and Wegovy. FDA sent it a warning letter on February 20, 2026.

1 FDA letterwarning letter about GLP-1 drugs, latest February 20, 2026
What other sellers showLowest monthly prices on 297 sellers’ sites, November 20, 2026Lowest 10% of sellers$39Median, semaglutide$118Median, tirzepatide$169Highest 10% of sellers$199What other sellers showLowest monthly prices on 297 sellers’ sites,November 20, 2026Lowest 10% of sellers$39Median, semaglutide$118Median, tirzepatide$169Highest 10% of sellers$199

Its own site shows no monthly price we could read; these are what other sellers show.

On this page

What do its site and FDA’s records show?

Websitemedvi.org
Drugs named on its siteOzempic, Wegovy
Compounded versionsNamed on its site
Lowest monthly price shownNone shown
Semaglutide fromNo price shown
Tirzepatide fromNo price shown
Pharmacy namedNone named
LegitScript mark or linkOn its site
Sold “for research use only”Not on the pages read
FDA warning letters on GLP-1 drugs1

What does its own site say?

We read 1 page of medvi.org on November 20, 2026. These are the sentences the facts above come from, word for word.

A seller can change its prices and wording at any time; the date above is when we read them.

What did FDA write to MEDVi?

On February 20, 2026 FDA sent MEDVi, LLC dba MEDVi a warning letter under the subject “False & Misleading Claims/Misbranded (Telehealth)”. It quotes the site, for example: Same active ingredient as Wegovy® and Ozempic®.

Read the facts and the full text of the letter.

Is the price I was quoted high or low?

Enter a monthly price. The chart places it among the lowest monthly prices that 297 sellers show on their own sites.

Price check297 sellers with a price
Drug
Sellers showing less—
Median price shown—

Which sellers show a lower price and have no FDA letter?

245 sellers in our database name the same drugs, show a lower monthly price and have no FDA warning letter about GLP-1 drugs. The six lowest:

The lowest price a site shows is often a first month, a membership fee or the smallest dose; read the sentence on each seller’s page before comparing.

How can I check MEDVi myself?

  1. Look the pharmacy up. A compounded GLP-1 is filled by a pharmacy, not by the telehealth company; ask which one, and check its license with the state board of pharmacy. FDA’s BeSafeRx page explains the warning signs of an unsafe online pharmacy.2
  2. Check certification yourself. A LegitScript badge on a site is not proof; LegitScript’s own lookup shows whether a website is certified.3
  3. Read what FDA says about compounded and unapproved GLP-1 drugs before paying for one.4
  4. Search the seller in our database of FDA warning letters.

Sources

  1. MEDVi. Page of its website, read on November 20, 2026. medvi.org
  2. FDA. BeSafeRx: your source for online pharmacy information. fda.gov
  3. LegitScript. Website certification status lookup. legitscript.com
  4. FDA. Concerns with unapproved GLP-1 drugs used for weight loss. fda.gov
  5. FDA. Warning letter to MEDVi, LLC dba MEDVi, February 20, 2026. Dose Insider summary with the link to fda.gov

Log every dose in mg with the vial it came from, so there is a record if something goes wrong.

Open Dose Insider